C1-Inhibitor protects from focal brain trauma in a cortical cryolesion mice model by reducing Thrombo-Inflammation

Frontiers in Cellular Neuroscience

Volumn 8, Issue SEP, 2014, Pages

  Albert Weissenberger, Christiane ^a   Mencl, Stine ^a   Schuhmann, Michael K ^a   Salur, Irmak ^a   Göb, Eva ^a   Langhauser, Friederike ^a   Hopp, Sarah ^a   Hennig, Nelli ^a   Meuth, Sven G ^b   Nolte, Marc W ^c   Sirén, Anna Leena ^a   Kleinschnitz, Christoph ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c CSL BEHRING GMBH   (Germany)

Author keywords

Blood brain barrier; C1 inhibitor; Contact kinin system; Edema; Inflammation; Thrombosis; Traumatic brain injury

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; PLASMA KININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX LESION; BRAIN EDEMA; CONTROLLED STUDY; FEMALE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; THROMBOSIS; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

EID: 84908311675     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00269     Document Type: Article

References (62)

1. Albert-Weissenberger, C., and Sirén, A. L. (2010). Experimental traumatic brain injury. Exp. Transl. Stroke Med.2:16. doi: 10.1186/2040-7378-2-16
2. Albert-Weissenberger, C., Sirén, A. L., and Kleinschnitz, C. (2013). Ischemic stroke and traumatic brain injury: the role of the kallikrein-kinin system. Prog. Neurobiol. 101-102, 65-82. doi: 10.1016/j.pneurobio.2012.11.004
3. Albert-Weissenberger, C., Stetter, C., Meuth, S. G., Gobel, K., Bader, M., Sirén, A. L., et al. (2012). Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation. J. Cereb. Blood Flow Metab. 32, 1747-1756. doi: 10.1038/jcbfm.2012.62
4. Auer, L. M., and Ott, E. (1979). Disturbances of the coagulatory system in patients with severe cerebral trauma II. Platelet function. Acta Neurochir. (Wien) 49, 219-226. doi: 10.1007/bf01808961
5. Banerji, A. (2010). Current treatment of hereditary angioedema: an update on clinical studies. Allergy Asthma Proc. 31, 398-406. doi: 10.2500/aap.2010.31.3387
6. Begieneman, M. P., Kubat, B., Ulrich, M. M., Hahn, N. E., Stumpf-Stolker, Y., Tempelaars, M., et al. (2012). Prolonged C1 inhibitor administration improves local healing of burn wounds and reduces myocardial inflammation in a rat burn wound model. J. Burn Care Res. 33, 544-551. doi: 10.1097/BCR.0b013e31823bc2fc
7. Björkqvist, J., Jämsä, A., and Renné, T. (2013). Plasma kallikrein: the bradykinin-producing enzyme. Thromb. Haemost. 110, 399-407. doi: 10.1160/TH13-03-0258
8. Caccia, S., Castelli, R., Maiocchi, D., Bergamaschini, L., and Cugno, M. (2011). Interaction of C1 inhibitor with thrombin on the endothelial surface. Blood Coagul. Fibrinolysis 22, 571-575. doi: 10.1097/MBC.0b013e3283494ba7
9. Cai, S., and Davis, A. E. 3rd. (2003). Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J. Immunol. 171, 4786-4791. doi: 10.4049/jimmunol.171.9.4786
10. Caliezi, C., Wuillemin, W. A., Zeerleder, S., Redondo, M., Eisele, B., and Hack, C. E. (2000). C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema.Pharmacol. Rev. 52, 91-112.
11. Camargo, A. C., Shapanka, R., and Greene, L. J. (1973). Preparation, assay and partial characterization of a neutral endopeptidase from rabbit brain. Biochemistry 12, 1838-1844. doi: 10.1021/bi00733a028
12. Cederberg, D., and Siesjo, P. (2010). What has inflammation to do with traumatic brain injury? Childs Nerv. Syst.26, 221-226. doi: 10.1007/s00381-009-1029-x
13. Cooper, D. J., Rosenfeld, J. V., Murray, L., Arabi, Y. M., Davies, A. R., D'Urso, P., et al. (2011). Decompressive craniectomy in diffuse traumatic brain injury. N. Engl. J. Med. 364, 1493-1502. doi: 10.1056/NEJMoa1102077
14. Coppola, L., Guastafierro, S., Verrazzo, G., Coppola, A., De Lucia, D., and Tirelli, A. (2002). C1 inhibitor infusion modifies platelet activity in hereditary angioedema patients. Arch. Pathol. Lab. Med. 126, 842-845.
15. Davis, A. E. 3rd, Lu, F., and Mejia, P. (2010). C1 inhibitor, a multi-functional serine protease inhibitor. Thromb. Haemost. 104, 886-893. doi: 10.1160/TH10-01-0073
16. Davis, A. E. 3rd, Mejia, P., and Lu, F. (2008). Biological activities of C1 inhibitor. Mol. Immunol. 45, 4057-4063. doi: 10.1016/j.molimm.2008.06.028
17. de Jager, S. C., Bot, I., Kraaijeveld, A. O., Korporaal, S. J., Bot, M., van Santbrink, P. J., et al. (2013). Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation.Arterioscler. Thromb. Vasc. Biol. 33, e75-e83. doi: 10.1161/ATVBAHA.112.300857
18. Dickneite, G. (1993). Influence of C1-inhibitor on inflammation, edema and shock. Behring Inst. Mitt. 93, 299-305.
19. Dietrich, W. D., Alonso, O., Busto, R., Prado, R., Dewanjee, S., Dewanjee, M. K., et al. (1996). Widespread hemodynamic depression and focal platelet accumulation after fluid percussion brain injury: a double-label autoradiographic study in rats. J. Cereb. Blood Flow Metab. 16, 481-489. doi: 10.1097/00004647-199605000-00015
20. Duehrkop, C., and Rieben, R. (2014). Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition. Biochem. Pharmacol. 88, 12-22. doi: 10.1016/j.bcp.2013.12.013
21. Ellis, E. F., Chao, J., and Heizer, M. L. (1989). Brain kininogen following experimental brain injury: evidence for a secondary event. J. Neurosurg. 71, 437-442. doi: 10.3171/jns.1989.71.3.0437
22. Farace, E., and Alves, W. M. (2000). Do women fare worse: a metaanalysis of gender differences in traumatic brain injury outcome. J. Neurosurg. 93, 539-545. doi: 10.3171/jns.2000.93.4.0539
23. Fiane, A. E., Videm, V., Johansen, H. T., Mellbye, O. J., Nielsen, E. W., and Mollnes, T. E. (1999). C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model. Immunopharmacology 42, 231-243. doi: 10.1016/s0162-3109(99)00008-9
24. Helmy, A., De Simoni, M. G., Guilfoyle, M. R., Carpenter, K. L., and Hutchinson, P. J. (2011). Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury. Prog. Neurobiol. 95, 352-372. doi: 10.1016/j.pneurobio.2011.09.003
25. Heydenreich, N., Nolte, M. W., Gob, E., Langhauser, F., Hofmeister, M., Kraft, P., et al. (2012). C1-inhibitor protects from brain ischemia-reperfusion injury by combined antiinflammatory and antithrombotic mechanisms. Stroke 43, 2457-2467. doi: 10.1161/STROKEAHA.112.660340
26. Horstick, G., Heimann, A., Gotze, O., Hafner, G., Berg, O., Boehmer, P., et al. (1997). Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation 95, 701-708. doi: 10.1161/01.cir.95.3.701
27. Hyder, A. A., Wunderlich, C. A., Puvanachandra, P., Gururaj, G., and Kobusingye, O. C. (2007). The impact of traumatic brain injuries: a global perspective. NeuroReabilitation 22, 341-353.
28. Johnson, E. A., Dao, T. L., Guignet, M. A., Geddes, C. E., Koemeter-Cox, A. I., and Kan, R. K. (2011). Increased expression of the chemokines CXCL1 and MIP-1alpha by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats. J. Neuroinflammation 8:41. doi: 10.1186/1742-2094-8-41
29. Kariya, K., Yamauchi, A., and Sasaki, T. (1985). Regional distribution and characterization of kinin in the CNS of the rat. J. Neurochem. 44, 1892-1897. doi: 10.1111/j.1471-4159.1985.tb07185.x
30. Keating, G. M. (2009). Human C1-esterase inhibitor concentrate (Berinert). BioDrugs 23, 399-406. doi: 10.2165/11201100-000000000-00000
31. Kizuki, K., Suzuki, T., Kudo, M., and Noguchi, T. (1994). Immunohistochemical demonstration of tissue kallikrein in the neurons of rat brain. Brain Res. 634, 305-309. doi: 10.1016/0006-8993(94)91934-8
32. Kleinschnitz, C., Grund, H., Wingler, K., Armitage, M. E., Jones, E., Mittal, M., et al. (2010). Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol. 8:e1000479. doi: 10.1371/journal.pbio.1000479
33. Kleinschnitz, C., Kraft, P., Dreykluft, A., Hagedorn, I., Göbel, K., Schuhmann, M. K., et al. (2013). Regulatory T cells are strong promotors of acute ischemic stroke in mice by inducung disfunction of the cerebral microvasculature.Blood 121, 679-691. doi: 10.1182/blood-2012-04-426734
34. Langhauser, F., Gob, E., Kraft, P., Geis, C., Schmitt, J., Brede, M., et al. (2012). Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage and inflammation. Blood120, 4082-4092. doi: 10.1182/blood-2012-06-440057
35. Lehmann, T., Heger, M., Münch, S., Kirschfinkm, M., and Klar, E. (2000). In vivo microscopy reveals that complement inhibition by C1-esterase inhibitor reduces ischemia/reperfusion injury in the liver. Transpl. Int. 13, S547-S550. doi: 10.1111/j.1432-2277.2000.tb02101.x
36. Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408. doi: 10.1006/meth.2001.1262
37. Longhi, L., Perego, C., Ortolano, F., Zanier, E. R., Bianchi, P., Stocchetti, N., et al. (2009). C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice. Crit. Care Med. 37, 659-665. doi: 10.1097/CCM.0b013e318195998a
38. Longhi, L., Perego, C., Zanier, E. R., Ortolano, F., Bianchi, P., Stocchetti, N., et al. (2008). Neuroprotective effect of C1-inhibitor following traumatic brain injury in mice. Acta Neurochir. Suppl. 102, 381-384. doi: 10.1007/978-3-211-85578-2_73
39. Lu, D., Mahmood, A., Goussev, A., Qu, C., Zhang, Z. G., and Chopp, M. (2004). Delayed thrombosis after traumatic brain injury in rats. J. Neurotrauma 21, 1756-1766. doi: 10.1089/0897715042664885
40. Magnus, T., Wiendl, H., and Kleinschnitz, C. (2012). Immune mechanisms of stroke. Curr. Opin. Neurol. 25, 334-340. doi: 10.1097/WCO.0b013e328352ede6
41. Martinez-Saguer, I., Cicardi, M., Suffritti, C., Rusicke, E., Aygören-Pürsün, E., Stoll, H., et al. (2014). Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study. Transfusion 54, 1552-1561. doi: 10.1111/trf.12501
42. Mejia, P., and Davis, A. E. 3rd. (2012). C1 inhibitor suppresses the endotoxic activity of a wide range of lipopolysaccharides and interacts with live gram-negative bacteria. Shock 38, 220-225. doi: 10.1097/shk.0b013e31825bf40e
43. Morganti-Kossman, M. C., Rancan, M., Stahel, P. F., and Kossmann, T. (2002). Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr. Opin. Crit. Care 8, 101-105. doi: 10.1097/00075198-200204000-00002
44. Nieswandt, B., Kleinschnitz, C., and Stoll, G. (2011). Ischaemic stroke: a thrombo-inflammatory disease? J. Physiol.589, 4115-4123. doi: 10.1113/jphysiol.2011.212886
45. Prodan, C. I., Vincent, A. S., and Dale, G. L. (2013). Coated-platelet levels are persistently elevated in patients with mild traumatic brain injury. J. Head Trauma Rehabil. doi: 10.1097/htr.0000000000000010. [Epub ahead of print].
46. Ramos, C. D., Canetti, C., Souto, J. T., Silva, J. S., Hogaboam, C. M., Ferreira, S. H., et al. (2005). MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4. J. Leukoc. Biol. 78, 167-177. doi: 10.1189/jlb.0404237
47. Raslan, F., Albert-Weissenberger, C., Ernestus, R. I., Kleinschnitz, C., and Sirén, A. L. (2012). Focal brain trauma in the cryogenic lesion model in mice. Exp. Transl. Stroke Med. 4:6. doi: 10.1186/2040-7378-4-6
48. Raslan, F., Schwarz, T., Meuth, S. G., Austinat, M., Bader, M., Renne, T., et al. (2010). Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J. Cereb. Blood Flow Metab. 30, 1477-1486. doi: 10.1038/jcbfm.2010.28
49. Ratcliff, J. J., Greenspan, A. I., Goldstein, F. C., Stringer, A. Y., Bushnik, T., Hammond, F. M., et al. (2007). Gender and traumatic brain injury: do the sexes fare differently? Brain Inj. 21, 1023-1030. doi: 10.1080/02699050701633072
50. Reichel, C. A., Puhr-Westerheide, D., Zuchtriegel, G., Uhl, B., Berberich, N., Zahler, S., et al. (2012). C-C motif chemokine CCL3 and canonical neutrophil attractants promote neutrophil extravasation through common and distinct mechanisms. Blood 120, 880-890. doi: 10.1182/blood-2012-01-402164
51. Renné, T. (2012). The procoagulant and proinflammatory plasma contact system. Semin. Immunopathol. 34, 31-41. doi: 10.1007/s00281-011-0288-2
52. Roozenbeek, B., Maas, A. I., and Menon, D. K. (2013). Changing patterns in the epidemiology of traumatic brain injury. Nat. Rev. Neurol. 9, 231-236. doi: 10.1038/nrneurol.2013.22
53. Schmidt, O. I., Heyde, C. E., Ertel, W., and Stahel, P. F. (2005). Closed head injury-an inflammatory disease? Brain Res. Brain Res. Rev. 48, 388-399. doi: 10.1016/j.brainresrev.2004.12.028
54. Schwarzmaier, S. M., Kim, S.-W., Trabold, R., and Plesnila, N. (2010). Temporal profile of thrombogenesis in the cerebral microcirculation after traumatic brain injury in mice. J. Neurotrauma 27, 121-130. doi: 10.1089/neu.2009.1114
55. Schwarzmaier, S. M., Zimmermann, R., Mcgarry, N. B., Trabold, R., Kim, S. W., and Plesnila, N. (2013). In vivo temporal and spatial profile of leukocyte adhesion and migration after experimental traumatic brain injury in mice.J. Neuroinflammation 10:32. doi: 10.1186/1742-2094-10-32
56. Shlosberg, D., Benifla, M., Kaufer, D., and Friedman, A. (2010). Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 6, 393-403. doi: 10.1038/nrneurol.2010.74
57. Sillesen, M., Johansson, P. I., Rasmussen, L. S., Jin, G., Jepsen, C. H., Imam, A. M., et al. (2013). Platelet activation and dysfunction in a large-animal model of traumatic brain injury and hemorrhage. J. Trauma Acute Care Surg. 74, 1252-1259. doi: 10.1097/TA.0b013e31828c7a6b
58. Tei, R., Kaido, T., Nakase, H., and Sakaki, T. (2008). Protective effect of C1 esterase inhibitor on acute traumatic spinal cord injury in the rat. Neurol. Res. 30, 761-767. doi: 10.1179/174313208x284241
59. Trabold, R., Eros, C., Zweckberger, K., Relton, J., Beck, H., Nussberger, J., et al. (2010). The role of bradykinin B(1) and B(2) receptors for secondary brain damage after traumatic brain injury in mice. J. Cereb. Blood Flow Metab.30, 130-139. doi: 10.1038/jcbfm.2009.196
60. Unterberg, A., Dautermann, C., Baethmann, A., and Müller-Esterl, W. (1986). The kallikrein-kinin system as mediator in vasogenic brain edema. Part 3: inhibition of the kallikrein-kinin system in traumatic brain swelling. J. Neurosurg. 64, 269-276. doi: 10.3171/jns.1986.64.2.0269
61. van Buul, J. D., and Hordijk, P. L. (2004). Signaling in leukocyte transendothelial migration. Arterioscler. Thromb. Vasc. Biol. 24, 824-833. doi: 10.1161/01.atv.0000122854.76267.5c
62. Wagner, A. K., Fabio, A., Puccio, A. M., Hirschberg, R., Li, W., Zafonte, R. D., et al. (2005). Gender associations with cerebrospinal fluid glutamate and lactate/pyruvate levels after severe traumatic brain injury. Crit. Care Med. 33, 407-413. doi: 10.1097/01.ccm.0000153931.23488.dd